Summary of the report:
Hemostasis Global Clinical Trials Review, H1, 2016” provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Request Sample Brochure Here @

Benefits of report:

    • The report provides a snapshot of the global clinical trials landscape
    • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    • The Report provides enrollment trends for the past five years
    • Report provides latest news for the past three months

Report helps you in:

    • Assists in formulating key business strategies with regards to investment
    • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
    • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
    • Supports understanding of trials count and enrollment trends by country in global therapeutics market
    • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    • Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies mentioned in the report:
Baxter International Inc.  Johnson & Johnson  Novo  A/S LAL Clinica Pesquisa e Desenvolvimento Ltda Takeda Pharmaceutical Company Limited ZymoGenetics, Inc. The Medicines Company Teva Pharmaceutical Industries Limited Omrix Biopharmaceuticals, Inc. Bristol-Myers Squibb Company

Inquire more Here @

About us:
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

Contact us:
Sales Manager
Mayur S

2711 Centerville Road, Suite 400,
United States
Telephone: 1-302-684-6088